Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of biological variables to predict outcome in multiple myeloma.

British journal of haematology - 1 Dec 1997

Davies F E, Jack A S, Morgan G J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Resorption
Share to Cell Adhesion Molecules
Share to Cell Survival
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Immunologic Deficiency Syndromes

Share to Multiple Myeloma

Share to Translocation, Genetic

Source

Identifiers

PMID: 9432013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of biological variables to predict outcome in multiple myeloma.PMID 9432013Read ↗

Genotypic and phenotypic characteristics of multiple myeloma.Semantic proximity Read ↗

Deciding on the therapy of multiple myeloma using genetic risk stratification.Semantic proximity Read ↗

Advances in understanding prognosis in myeloma.Semantic proximity Read ↗

Role of genetics in prognostication in myelomaSemantic proximity Read ↗

Increased LDH Remains a Crucial Prognostic Factor in Patients with Multiple Myeloma.Semantic proximity Read ↗

V. Molecular classification and risk stratification of myeloma.Semantic proximity Read ↗

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenSemantic proximity Read ↗

Defining and treating high-risk multiple myelomaSemantic proximity Read ↗

Genetic mutations and outcome in myeloma.Semantic proximity Read ↗

Gene signature combinations improve prognostic stratification of multiple myeloma patientsSemantic proximity Read ↗

Prognostic and predictive markers in hematologic neoplasms. A review.Semantic proximity Read ↗

Prognostic factors and staging in multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.